322 related articles for article (PubMed ID: 21475311)
1. Novel drug delivery systems for glaucoma.
Lavik E; Kuehn MH; Kwon YH
Eye (Lond); 2011 May; 25(5):578-86. PubMed ID: 21475311
[TBL] [Abstract][Full Text] [Related]
2. [Progression of drug delivery system for glaucoma].
Xu Y; Lyu L
Zhonghua Yan Ke Za Zhi; 2014 Dec; 50(12):946-51. PubMed ID: 25619186
[TBL] [Abstract][Full Text] [Related]
3. Sustained release ocular drug delivery systems for glaucoma therapy.
Al-Qaysi ZK; Beadham IG; Schwikkard SL; Bear JC; Al-Kinani AA; Alany RG
Expert Opin Drug Deliv; 2023; 20(7):905-919. PubMed ID: 37249548
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery by contact lens in spontaneously glaucomatous dogs.
Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
[TBL] [Abstract][Full Text] [Related]
5. Sustained drug delivery in glaucoma.
Knight OJ; Lawrence SD
Curr Opin Ophthalmol; 2014 Mar; 25(2):112-7. PubMed ID: 24463419
[TBL] [Abstract][Full Text] [Related]
6. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
[TBL] [Abstract][Full Text] [Related]
7. Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop.
Fedorchak MV; Conner IP; Schuman JS; Cugini A; Little SR
Sci Rep; 2017 Aug; 7(1):8639. PubMed ID: 28819134
[TBL] [Abstract][Full Text] [Related]
8. Current and new pharmacotherapeutic approaches for glaucoma.
Shalaby WS; Shankar V; Razeghinejad R; Katz LJ
Expert Opin Pharmacother; 2020 Nov; 21(16):2027-2040. PubMed ID: 32717157
[TBL] [Abstract][Full Text] [Related]
9. Extended drug delivery by contact lenses for glaucoma therapy.
Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
J Control Release; 2012 Aug; 162(1):152-8. PubMed ID: 22721817
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.
Chen YS; Green CR; Danesh-Meyer HV; Rupenthal ID
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):182-93. PubMed ID: 25676338
[TBL] [Abstract][Full Text] [Related]
11. A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method.
Woodward DF; Wang JW; Coleman RA; Woodrooffe AJ; Clark KL; Stamer WD; Tao G; Fan S; Toris CB
J Ocul Pharmacol Ther; 2019 Jun; 35(5):265-277. PubMed ID: 31025909
[No Abstract] [Full Text] [Related]
12. Rho Kinase Inhibitors and Novel Ocular Drug Delivery Systems- A Revolutionary Step Towards the Treatment of Glaucoma.
Abbhi V; Piplani P
Curr Drug Deliv; 2016; 13(6):818-29. PubMed ID: 23855668
[TBL] [Abstract][Full Text] [Related]
13. Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SOA; Cronemberger S; Nogueira JC; Ferreira AJ; Faraco AAG
Int J Pharm; 2019 Oct; 570():118662. PubMed ID: 31491481
[TBL] [Abstract][Full Text] [Related]
14. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Dec; 116(12):2286-93. PubMed ID: 19815286
[TBL] [Abstract][Full Text] [Related]
15. Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.
Kompella UB; Hartman RR; Patil MA
Prog Retin Eye Res; 2021 May; 82():100901. PubMed ID: 32891866
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
17. Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.
Chiang B; Kim YC; Doty AC; Grossniklaus HE; Schwendeman SP; Prausnitz MR
J Control Release; 2016 Apr; 228():48-57. PubMed ID: 26930266
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.
Lusthaus JA; Goldberg I
Expert Opin Emerg Drugs; 2016; 21(1):117-28. PubMed ID: 26854598
[TBL] [Abstract][Full Text] [Related]
19. Lollipop-Inspired Multilayered Drug Delivery Hydrogel for Dual Effective, Long-Term, and NIR-Defined Glaucoma Treatment.
Wang F; Song Y; Huang J; Wu B; Wang Y; Pang Y; Zhang W; Zhu Z; Ma F; Wang X; Zhang X
Macromol Biosci; 2021 Nov; 21(11):e2100202. PubMed ID: 34405963
[TBL] [Abstract][Full Text] [Related]
20. Patient attitudes toward novel glaucoma drug delivery approaches.
Wang BB; Lin MM; Nguyen T; Turalba AV
Digit J Ophthalmol; 2018; 24(2):16-23. PubMed ID: 30800009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
